Literature DB >> 15693206

[Mood disorders, psychopharmacology and thyroid hormones].

Quiroz Danilo1, Sergio Gloger, Sergio Valdivieso, José Ivelic, Carlos Fardella.   

Abstract

For more than 40 years thyroid hormones and mood disorders have been associated. Some psychiatric symptoms are produced by thyroid illnesses and there is a frequent association of thyroid dysfunction with mood disorders. Therefore, routine thyroid function assessment in patients with mood disorders and the treatment of sub-clinical thyroid dysfunctions is recommended. The usefulness of adding thyroid hormones to antidepressive treatment in euthyroid patients to obtain a potentiation effect has been probed repeatedly. The most common strategy is potentiation with T3, but high doses of T4 have been also used in patients with resistant depression. Thyroid hormones exert their action in the central nervous system through a variety of mechanisms: modulation of gene expression of several groups of proteins, some of them with known physiopathological implications in mood disorders and the influence over serotonin and noradrenergic neurotransmission, known to be one of the modes of action of antidepressants. Finally, it is also important to stress the complex relationship between psychiatric drugs, deiodinases and thyroid hormones, that can potentially help to understand the mechanisms of action of these drugs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15693206

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  3 in total

1.  Microstructural white matter abnormalities in hypothyroidism evaluation with diffusion tensor imaging tract-based spatial statistical analysis.

Authors:  Hediye Pınar Gunbey; Arzu Ceylan Has; Kerim Aslan; Dilek Saglam; Ugur Avcı; Aslı Tanrıvermis Sayıt; Lutfi Incesu
Journal:  Radiol Med       Date:  2020-06-10       Impact factor: 3.469

2.  Refractory depression in a patient with peripheral resistance to thyroid hormone (RTH) and the effect of triiodothyronine treatment.

Authors:  Carlos E Fardella; Rocío A Artigas; Sergio Gloger; Marcela Jiménez; Cristian A Carvajal; Paola M Krall; Danilo Quiroz; Carmen Campino; Lorena M Mosso
Journal:  Endocrine       Date:  2007-06       Impact factor: 3.633

3.  Evaluating the extent of pregravid risk factors of gestational diabetes mellitus in women in tehran.

Authors:  S Sh Hoseini; S Hantoushzadeh; S Shoar
Journal:  Iran Red Crescent Med J       Date:  2011-06-01       Impact factor: 0.611

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.